Finance

Lists
PRE:NASDAQ
Prenetics Global Ltd
$24.34
+0.62%
(+0.15) 1D
$24.34
0.00% (0.00)
After hours
Closed: Sep 21, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PRE...
Open
$24.70
High
$25.01
Low
$23.76
Mkt. cap
417.27M
Avg. vol.
252.75K
Volume
112.65K
52-wk high
$27.24
52-wk low
$11.36
EPS
-$2.88
Beta
0.38
Shares outstanding
15.56M
No. of employees
98
Open
$24.70
High
$25.01
Low
$23.76
Mkt. cap
417.27M
Avg. vol.
252.75K
Volume
112.65K
52-wk high
$27.24
52-wk low
$11.36
EPS
-$2.88
Beta
0.38
Shares outstanding
15.56M
No. of employees
98
News stories
From web sources and news partners
Profile
Prenetics is a health sciences company headquartered in Hong Kong, with a presence in the United States. It focuses on early detection, prevention, and treatment of diseases, particularly cancer. Its subsidiary brands include CircleDNA, Insighta and IM8. Wikipedia
About Prenetics Global Ltd
CEO-
Employees98
Founded2014
Headquarters-
SectorHealth care provider
Websiteprenetics.com
Analyst ratings
Based on 6 analysts giving stock ratings to PRE in the past 3 months
Strong buy
Buy
6
Hold
0
Sell
0
12-month forecast
Based on 6 Wall Street analysts offering 12 month price targets for PRE in the last 3 months.
Highest
Current $24.34
$40.00 (+64.34%)
Average
$38.00 (+56.12%)
Lowest
$35.00 (+43.80%)
Analyst
Recommendation
Action
Price target
Projected
Date
Eric Des Lauriers
Craig-Hallum
Buy
Initiated
$40.00
+64.3%
09/17/2026
Unknown Analyst
StoneX
Buy
Reiterated
$40.00
+64.3%
09/08/2026
Jeff Van Sinderen
B. Riley Securities
Buy
Initiated
$37.00
+52%
08/27/2026
Ryan Meyers
Lake Street
Buy
Reiterated
$35.00
+43.8%
08/19/2026
George Kelly
Roth MKM
Buy
Maintained
$36.00
+47.9%
08/19/2026
Bill Sutherland
Benchmark Co.
Buy
Maintained
$40.00
+64.3%
07/15/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
23.56M
36.56M
35.95M
46.49M
Cost of goods sold
9.53M
14.97M
12.67M
16.28M
Cost of revenue
9.53M
14.97M
12.67M
16.28M
Research and development expenses
1.17M
743.00K
1.44M
757.00K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
19.41M
34.13M
31.55M
51.36M
Operating expense
20.19M
35.17M
32.15M
51.18M
Total operating expenses
29.72M
50.14M
44.82M
67.47M
Operating income
-6.16M
-13.58M
-8.87M
-20.98M
Other non operating income
96.00K
9.59M
-17.86M
9.28M
EBT including unusual items
-6.78M
-9.66M
-27.31M
-9.08M
EBT excluding unusual items
-6.78M
-3.87M
-26.74M
-11.71M
Income tax expense
9.00K
38.00K
28.00K
5.00K
Effective tax rate
-0.13%
-0.39%
-0.10%
-0.06%
Other operating expenses
-395.00K
297.00K
-840.00K
-941.00K
Net income
-7.41M
-7.50M
-23.10M
-8.98M
Net profit margin
-31.45%
-20.52%
-64.26%
-19.32%
Earnings per share
-
-0.19
-
-0.52
Interest and investment income
-
1.20M
-
-
Interest expense
-55.00K
-45.00K
-9.00K
-13.00K
Net interest expenses
-55.00K
1.15M
-9.00K
-13.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-5.33M
-13.34M
-8.71M
-20.80M
Gain or loss from assets sale
-
-
-253.00K
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps